Data Insights

Soquelitinib by Corvus Pharmaceuticals for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval

Soquelitinib is under clinical development by Corvus Pharmaceuticals and currently in Phase I for Atopic Dermatitis (Atopic Eczema). According to...

Likelihood of Approval and Phase Transition Success Rate Model - Soquelitinib in Atopic Dermatitis (Atopic Eczema)

Data Insights

Soquelitinib by Corvus Pharmaceuticals for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval

Soquelitinib is under clinical development by Corvus Pharmaceuticals and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to...

Likelihood of Approval and Phase Transition Success Rate Model - Soquelitinib in Peripheral T-Cell Lymphomas (PTCL)

Data Insights

Soquelitinib by Corvus Pharmaceuticals for T-Cell Lymphomas: Likelihood of Approval

Soquelitinib is under clinical development by Corvus Pharmaceuticals and currently in Phase II for T-Cell Lymphomas. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Soquelitinib in T-Cell Lymphomas

Data Insights

Soquelitinib by Corvus Pharmaceuticals for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy: Likelihood of Approval

Soquelitinib is under clinical development by Corvus Pharmaceuticals and currently in Phase III for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy. According...

Data Insights

Soquelitinib by Corvus Pharmaceuticals for Follicular Lymphoma: Likelihood of Approval

Soquelitinib is under clinical development by Corvus Pharmaceuticals and currently in Phase III for Follicular Lymphoma. According to GlobalData, Phase...

Data Insights

Soquelitinib by Corvus Pharmaceuticals for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval

Soquelitinib is under clinical development by Corvus Pharmaceuticals and currently in Phase III for Anaplastic Large Cell Lymphoma (ALCL). According...